Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Assisted Reproduction
U.S. patent approved for in vitro fertilization media
March 17th, 2005
Vitrolife has been informed that the company's patent application regarding the use of alanyl-glutamine in media for in vitro fertilization has been approved in the U.S. "The advantage of alanyl-glutamine compared with glutamine, which was used previously, is that it is more stable and is not broken down into harmful substances that can inhibit the development of the embryo. The approval of this patent entails a competitive advantage for the company," says Magnus Nilsson, Vitrolife's CEO. Vitrolife has been informed that patent no. 6,838,235, designated "Methods for in vitro fertilization," has been approved by the American patent authority. ...
Source: Women's Health Weekly (2005-03-17)
|
